Our data suggest that aberrant expression of the hPer2 gene may be associated with the development of carcinomas in the colorectal tissues and may provide a molecular basis for the clinical application of chronotherapy in CRC treatment. This evidence concerns the gene PER2 and colorectal carcinoma.